Welcome to our dedicated page for Ionq SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IonQ, Inc. (NYSE: IONQ) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered summaries to help interpret complex documents. As a quantum platform company active in computing, networking, sensing, and security, IonQ uses its SEC filings to report on capital markets activity, acquisitions, governance changes, and executive compensation arrangements.
Investors can review Form 8-K filings where IonQ reports material events such as underwriting agreements for common stock, pre-funded warrants, and Series B warrants, as well as prospectus supplements covering resales of common stock by selling stockholders. Other 8-Ks describe unregistered sales of equity securities, registration rights agreements with institutions like Oxford Science Enterprises and Fortis Advisors, and the completion of acquisitions such as Oxford Ionics Limited and Vector Atomic, Inc.
Filings also detail board and executive changes. Recent 8-Ks and amendments outline the appointment of new directors, the transition of existing directors into advisory roles, and separation agreements for senior executives under IonQ’s Amended and Restated Executive Severance Plan. These documents specify cash severance, COBRA benefits, and equity vesting terms, providing insight into leadership transitions and compensation structures.
Through its registration statements and related supplements, IonQ discloses information about listed securities, including common stock and warrants trading on the New York Stock Exchange under the symbols IONQ and IONQ WS. AI-generated highlights on this page help users quickly identify key terms such as warrant exercise prices, expiration dates, and adjustment mechanisms, as well as the implications of registration rights and resale arrangements.
By using this filings page, readers can follow IonQ’s equity offerings, acquisition-related share issuances, insider and governance updates, and other regulatory disclosures, while AI summaries assist in understanding how each filing may relate to ownership, dilution, and the company’s strategic transactions.
IonQ, Inc. President and CEO Niccolo de Masi reported a tax-related share disposition. On March 11, 2026, he disposed of 20,785 shares of common stock at a weighted average price of $34.802 per share to satisfy tax liability from vesting RSUs, with trades executed between $33.69 and $35.87. After this transaction, he directly holds 1,155,667 shares of IonQ common stock, indicating the event is a small, routine adjustment to cover taxes rather than a discretionary open-market sale.
IonQ, Inc. said it intends to effect a proposed transaction with SkyWater Technology and will file a Registration Statement on Form S-4 that will include a prospectus for the IonQ common stock to be issued in the transaction. The definitive proxy statement/prospectus will be mailed to SkyWater stockholders when available.
The transcript of a March 10, 2026 interview describes IonQ's defense, sensing and cybersecurity work and references an announced acquisition of SkyWater; regulatory review, stockholder approval and customary closing conditions are stated as potential contingencies.
IonQ, Inc. is registering 2,562,642 shares of common stock for resale by The Chancellor, Masters, and Scholars of the University of Cambridge under a new prospectus supplement to its existing shelf registration statement. The prospectus supplement is required by a Registration Rights Agreement dated March 10, 2026. The shares were originally issued in a private transaction relying on exemptions under Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D, and IonQ has filed related legal opinion and consent exhibits.
IonQ, Inc. files a prospectus supplement to register up to 2,562,642 shares of its common stock for resale by a selling stockholder. The prospectus supplement states the company will not receive any proceeds from sales by the selling stockholder and that sales may occur on exchanges, OTC, privately, or by other permitted methods.
Shares outstanding were 366,640,756 as of February 18, 2026. The selling stockholder identified is The Chancellor, Masters, and Scholars of the University of Cambridge, which may sell any, all or none of the registered shares.
IONQ filed a Form 144 reporting the intended sale of 7,600 shares of Common Stock, tied to the 03/10/2026 vesting of Performance Stock Units. The filing also records a prior sale of 4,132 shares on 12/11/2025.
The notice lists the broker address shown on the form and classifies the transaction as equity compensation (vesting-driven). Timing and cash‑flow treatment beyond the filing entries are not included in the excerpt.
IONQ filed a Form 144 notice to sell 26,320 shares of Common Stock. The filing states the sale is tied to the vesting of Performance Stock Units on 03/10/2026 and lists the issuer as the selling party under an equity compensation arrangement.
The filing also shows a prior sale by Niccolo de Masi of 16,290 shares on 12/11/2025, shown in the form's recent activity section. The notice is a regulatory filing that signals planned resale following PSU vesting.
IONQ reported a Form 144 disclosing the proposed sale/transfer of 9,970 shares of Common Stock associated with the vesting of performance stock units on 03/10/2026. The filing lists the transaction as Equity Compensation and names the issuer in the distribution method.
The filing also records a prior sale by Inder M. Singh of 12,553 shares on 12/11/2025 as a sale during the past three months. The notice is a routine Rule 144 disclosure of intended resale/transfer tied to compensation vesting.
IONQ reports insider transactions and a vesting-related transfer. The filing shows 1,000 shares of Common Stock related to the vesting of Performance Stock Units on 03/10/2026 that were issued by the company. The filing also records sales by Robert T. Cardillo of 5,165 shares on 02/26/2026 and 3,071 shares on 02/27/2026.
IonQ, Inc. filed a supplement to its prospectus supplement to correct the Calculation of Registration Fee table by adding 280,958 shares of common stock to the Amount Registered. The supplement states this amendment only corrects the fee table and that no other changes were made to the prospectus supplement or accompanying prospectus.